using pt141 PT-141 (Bremelanotide) Peptide PT141

Ostatecznie musisz zdecydowa, komu ufa

No more than 1 injection per 24 hours, no more than 8 doses per month

GMP standartlarnda retim, hammaddeden son kullancya kadar olan srete hammadde , ileme, rn gelitirme, retim, paketleme, depolama, datm aamalarnda kesintisiz uygulanmas gereken bir kalite kontrol unsurudur

Clinical Studies The prolactin-lowering efficacy of DOSTINEX was demonstrated in 647 females with hyperprolactinemic disorders (including 55% microprolactinomas, 7% macroprolactinomas, 3% empty sella syndromes, and 3% idiopathic) in two randomized, double-blind, studies: one 4-week placebo-controlled dose-response study with an 12-month open-label extension (Study 1) and one 8-week active comparator study comparing DOSTINEX and bromocriptine with 16-week open extension (Study 2)